RecruitingNot ApplicableNCT05649072
Identifying Underserved Individuals inTexas With Hereditary Cancer Risk Using Mobile Mammography Units and Telegenetics.
Sponsor
M.D. Anderson Cancer Center
Enrollment
1,000 participants
Start Date
Nov 18, 2022
Study Type
INTERVENTIONAL
Conditions
Summary
Identifying women at risk for hereditary cancer potentiates prevention, early detection or personalised treatment against cancer. We using mobile mammography units will provide genetic sceening and testing services to underserved women coming for thier mammograms to these units.
Eligibility
Sex: FEMALEMin Age: 18 Years
Inclusion Criteria1
- Any woman scheduled at Project VALET mammography screening mobile units will be eligible for this study.
Interventions
BEHAVIORALGenetic Testing and Counseling
Participants will be asked to collect a saliva sample for hereditary cancer and genetic testing
BEHAVIORALScreening Form
Participant will be answering demographic details
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05649072
Related Trials
ESPERANZA: External Control Arm Study for T-DXd for Patients With HER2 IHC3+ Solid Tumors
NCT0697316127 locations
A Study to Evaluate the Safety, Tolerability, Drug Levels, and Preliminary Efficacy of BMS-986507 Combinations in Adult Participants With Advanced Solid Tumors
NCT0661828763 locations
Early Phase Study of KESONOTIDE™in Participants With Solid Tumours
NCT069260753 locations
Cardiac Outcomes With Near-Complete Estrogen Deprivation
NCT053096553 locations
Feasibility Evaluation of the Muse Magnetic Resonance Guided Focused Ultrasound System
NCT052915071 location